- Pharmaceutical companies
- Africa
- Egypt
- Novartis
Novartis in Egypt
Addresses:
-
Novartis Pharma S.A.E., Alexandria Site, 1, El-Fardous Street, Building (B), First floor, Apartment #101, Smouha, Alexandria, Egypt
-
Novartis Pharma S.A.E., Asyut Site, El Gomboriah Street, El Loaloah Tower, 5th Floor, Asyut, Egypt
-
Novartis Pharma S.A.E., El Mansoura Site, 53 Elgiesh Street, El Obour Tower, Beside Mansoura East District, El Dakahleya, El Mansoura, Egypt
-
Novartis Pharma S.A.E., El Sawah Street, 11511 Amiria, Cairo, Egypt
Phone: 20 2 2286 1000
Fax: 20 2 2450 5345
-
Novartis Pharma S.A.E., Sohag Site, 30 El-Nile Street, Dr. Ezzeldawla Elsharkawy Tower, Second floor, Gharb District, Sohag, Egypt
Phone: 20 93 230 3354
-
Novartis Pharma S.A.E., Tanta Site, 29, Elhayat Street, Beside Tanta Stadium, Tanta, Egypt
-
Sandoz Egypt Pharma S.A.E., 5th Assembly, Building 289, Second center, New Cairo City, Egypt
Web: https://www.sandoz.com.eg
Phone: 20 2 286 1600
Fax: 20 2 286 1601
-
Sandoz Egypt Pharma S.A.E., Alexandria Site, El-Fardous Building, El-Fardous Street, Apartment #304, Smouha, Alexandria, Egypt
-
Sandoz Egypt Pharma S.A.E., Asyut Site, 5 Street, 3 Takseem Elyas Belash, Asyut, Egypt
-
Sandoz Egypt Pharma S.A.E., El Mansoura Site, El-Sawsan Plaza Tower, El-Gomhouria Str., El Mansoura first district, Apt. 401, El Dakahlia Governorate, El Dakahleya, El Mansoura, Egypt
Other Novartis's locations around the world
-
Switzerland
-
Austria
-
Germany
-
Slovenia
-
Poland
-
France
-
Spain
-
Belgium
-
Romania
-
Italy
-
United Kingdom
-
Ukraine
-
Russia
-
Serbia
-
Slovakia
-
Sweden
-
Belarus
-
Bulgaria
-
Croatia
-
Czech Republic
-
Denmark
-
Estonia
-
Finland
-
Greece
-
Hungary
-
Iceland
-
Ireland
-
Latvia
-
Lithuania
-
Luxembourg
-
Macedonia
-
Malta
-
Montenegro
-
Netherlands
-
Norway
-
Portugal
-
Albania
-
Bosnia & Herzegovina
Clinical Trials sponsored by Novartis
-
Novartis PharmaceuticalsHar ikke rekruttert ennåAnti-nøytrofile cytoplasmaantistoffer (ANCA) assosiert vaskulitt
-
Novartis PharmaceuticalsHar ikke rekruttert ennåMultippel sklerose, tilbakefallende-remitterende
-
Novartis PharmaceuticalsHar ikke rekruttert ennåLeddgikt | Systemisk lupus erythematosus | Sjögrens sykdom
-
Novartis PharmaceuticalsHar ikke rekruttert ennåForhøyet Lp(a) og etablert aterosklerotisk kardiovaskulær sykdom
-
Novartis PharmaceuticalsRekrutteringTilbakevendende former for multippel skleroseSpania
-
Novartis PharmaceuticalsRekruttering
-
Novartis PharmaceuticalsHar ikke rekruttert ennå
-
Novartis PharmaceuticalsRekrutteringMultippel sklerose (MS)Frankrike
-
Novartis PharmaceuticalsHar ikke rekruttert ennå
-
Novartis PharmaceuticalsRekrutteringHR+HER2- Avansert brystkreftDen russiske føderasjonen
About Novartis
Novartis is structured to deliver innovative products, exploit global scale, and respond to new opportunities and risks. Our purpose is to reimagine medicine to improve and extend people's lives. We use innovative science and technology to address some of society's most challenging healthcare issues. We discover and develop breakthrough treatments and find new ways to deliver them to as many people as possible. We also aim to reward those who invest their money, time and ideas in our company.